Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia
- 1 December 1994
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 20 (6) , 933-940
- https://doi.org/10.1016/0741-5214(94)90230-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.Proceedings of the National Academy of Sciences, 1992
- Hyperhomocyst(e)inemia as a Risk Factor for Occlusive Vascular DiseaseAnnual Review of Nutrition, 1992
- Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine.Journal of Clinical Investigation, 1991
- Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteineAtherosclerosis, 1991
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serumJournal of Chromatography B: Biomedical Sciences and Applications, 1991
- Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease Effects of pyridoxine and folic acid treatmentAtherosclerosis, 1990
- Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial DiseaseNew England Journal of Medicine, 1985
- Homocystinuria — The Effects of Betaine in the Treatment of Patients Not Responsive to PyridoxineNew England Journal of Medicine, 1983